132 related articles for article (PubMed ID: 5082495)
1. Experiences in the use of fibrinolytic agents in Behcet's syndrome.
Kirk J; Handley DA
Australas J Dermatol; 1972 Apr; 13(1):5-10. PubMed ID: 5082495
[No Abstract] [Full Text] [Related]
2. Failure of colchicine and fibrinolytic therapy in Behçet's disease.
Graham-Brown RA; Sarkany I
Clin Exp Dermatol; 1980 Mar; 5(1):87-92. PubMed ID: 7398131
[No Abstract] [Full Text] [Related]
3. Preliminary report of beneficial effect of phenformin in combination with ethyloestrenol in treatment of cutaneous vasculitis and Behçet's syndrome.
Menon IS; Cunliffe WJ; Dewar HA
Postgrad Med J; 1969 May; 45():62-6. PubMed ID: 5364317
[No Abstract] [Full Text] [Related]
4. Treatment of Behcet's syndrome with phenformin and ethyloestrenol.
Cunliffe WJ; Menon IS
Lancet; 1969 Jun; 1(7608):1239-40. PubMed ID: 4182415
[No Abstract] [Full Text] [Related]
5. Behçet's syndrome and oral fibrinolytic therapy.
Cunliffe WJ; Roberts BE; Dodman B
Br Med J; 1973 May; 2(5864):486-7. PubMed ID: 4712497
[No Abstract] [Full Text] [Related]
6. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
Menon IS
Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
[No Abstract] [Full Text] [Related]
7. Phenformin and stanozolol in blood fibrinolytic activity.
Menon IS; Cunliffe WJ; Weightman D; Dewar HA
Br Med J; 1970 Feb; 1(5693):428. PubMed ID: 4244848
[No Abstract] [Full Text] [Related]
8. Behcet's syndrome: clinical, immunological and therapeutic evaluation of 17 patients.
Cooper DA; Penny R
Aust N Z J Med; 1974 Dec; 4(6):585-96. PubMed ID: 4533949
[No Abstract] [Full Text] [Related]
9. Malignant atrophic papulosis of Degos. Report of a patient who failed to respond to fibrinolytic therapy.
Howsden SM; Hodge SJ; Herndon JH; Freeman RG
Arch Dermatol; 1976 Nov; 112(11):1582-8. PubMed ID: 791153
[TBL] [Abstract][Full Text] [Related]
10. Phenformin and ethyloestrenol in recurrent deep venous thrombosis (DVT).
Hedner U; Nilsson IM; Isacson S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):372-80. PubMed ID: 63424
[No Abstract] [Full Text] [Related]
11. Effect of fibrinolytic treatment in malignant atrophic papulosis.
Delaney TJ; Black MM
Br Med J; 1975 Aug; 3(5980):415. PubMed ID: 1156791
[No Abstract] [Full Text] [Related]
12. Fibrinolytic activity and coronary-artery disease.
Naimi S; Proger S
Lancet; 1968 Jun; 1(7554):1250-1. PubMed ID: 4172804
[No Abstract] [Full Text] [Related]
13. Fibrinolytic therapy for vasculitis of atrophie blanche.
Gilliam JN; Herndon JH; Prystowsky SD
Arch Dermatol; 1974 May; 109(5):664-7. PubMed ID: 4828532
[No Abstract] [Full Text] [Related]
14. Oral fibrinolytic agents.
Fearnley GR; Chakrabarti R
Br Med J; 1968 Aug; 3(5616):498. PubMed ID: 5666808
[No Abstract] [Full Text] [Related]
15. Editorial: Fibrinolysis and venous thrombosis.
Br Med J; 1974 Nov; 4(5941):365-6. PubMed ID: 4425884
[No Abstract] [Full Text] [Related]
16. Pharmacological stimulation of fibrinolytic activity in the surgical patient.
Brown IK; Haggart B; Murray GH; Downie RJ; Littler J; Robb PM; Santer GJ
Lancet; 1971 Apr; 1(7703):774-6. PubMed ID: 4101274
[No Abstract] [Full Text] [Related]
17. Pharmacological fibrinolysis after surgical operations.
Lancet; 1971 Apr; 1(7703):789-90. PubMed ID: 4101283
[No Abstract] [Full Text] [Related]
18. Effects of platelet suppressant, anticoagulant and fibrinolytic therapy in patients with recurrent venous thrombosis.
Steele P; Ellis J; Genton E
Am J Med; 1978 Mar; 64(3):441-5. PubMed ID: 345802
[No Abstract] [Full Text] [Related]
19. Fibrinolysis in cutaneous vasculitis.
Cunliffe WJ
Proc R Soc Med; 1971 Sep; 64(9):928. PubMed ID: 5114293
[No Abstract] [Full Text] [Related]
20. Decreased fibrinolysis in Behçet's disease.
Chajek T; Aronowski E; Izak G
Thromb Diath Haemorrh; 1973 Jun; 29(3):610-8. PubMed ID: 4761829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
